Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Peptide receptor radionuclide therapy (PRRT) based on Lu-177 DOTATATE is currently used worldwide as a treatment option for neuroendocrine tumor patients. But until now, no PRRT has been approved by the Korea Food and Drug Administration (KFDA). Thus, neuroendocrine tumor patients in Korea have severely limited access to the treatment. To provide treatment opportunities, we have planned a First-in-Korea phase I clinical trial of SNU-KB-01, no-carrier added Lu-177 labeled DOTATATE.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Suh M, Cheon G, Lee D,
Keywords: PRRT, clinical trial, Neuroendocrine tumor, Lu-177-DOTATATE,
Introduction: 203Pb/212Pb is a promising theranostics pair for SSTR2-targeted alpha-particle therapy for neuroendocrine tumors (NETs). The development of SSTR2-targeted peptides that are optimized for the Pb isotopes has the potential to improve performance.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Lee D, Li M, Baumhover N, Liu D, Sagastume E,
Keywords: prrt, VMT-alpha-NET, 203Pb/212Pb theranostics,
Introduction: Guidelines recommend a watchful strategy for small, incidental, nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNEN).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Partelli S
Authors: Partelli S, Zerbi A, Massironi S, Jin-Young J, Landoni L,
Keywords: small neuroendocrine pancreatic tumors, surveillance, surgery, follow-up,
Introduction: In practice, many patients with NETs report a change in symptoms after starting somatostatin analogues (SSA’s). Many health professionals and NET patient advocates have noticed that some of the side effects experienced by patients are more common than patient information literature suggests. It is therefore important to ask what and how severe experiences are, and compare to literature, to help raise awareness amongst NET health professionals.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Whyand T, Davies P, Bouvier C,
Keywords: B12, SSA, Side effects, Fat soluble vitamins,
#1731 Neuroendocrine Neoplasm Trends over 32 Years in Queensland, Australia
Introduction: Incidence of Neuroendocrine neoplasms (NENs) has been increasing worldwide.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Wyld D